BAILLIE GIFFORD & CO

Q4 2022 13F-HR/A Holdings

Location
Edinburgh, X0
Holdings as of
12/31/2022
Date filed
3/10/2023
Form type
13F-HR/A - RESTATEMENT
Num holdings
489
Total value ($000)
$95,959,833
Net value change ($000)
-1,031,482 (-1.1%)
New positions
15
Sold out positions
13
Turnover %
1.4%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Snapshot: Change Analysis

Compared to Q3 2022
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
MRNA 2,690,232 50.2%
NVDA 684,671 36.9%
PDD 569,014 32.2%
DXCM 501,188 34.4%
NFLX 409,107 24.9%
MELI 396,228 8.3%
ISRG 345,654 43.9%
ALNY 331,307 17.4%
ONC 316,951 73.2%
ETN 227,905 NEW
Top Reduces (Value $000, Stocks/ETFs)
TSLA -4,091,340 -55.3%
AMZN -1,071,447 -25.2%
ABIOMED INC -889,365 -99.9%
META -673,528 -70.4%
TTD -552,178 -20.7%
NIO -345,913 -22.7%
ALB -263,633 -31.0%
ILMN -243,390 -6.7%
DNA -224,061 -35.2%
CVNA -219,965 -76.6%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type